These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8680882)

  • 1. Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism.
    Biswas DK; Tius MA; Zhuo J; Pardee AB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):120-7. PubMed ID: 8680882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT.
    Biswas DK; Mhashilkar AM; Ewaniuk DS; Pezza JA; Oh LM; Kannangara GS; Tius MA; Pardee AB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):426-34. PubMed ID: 9715838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
    Biswas DK; Ahlers CM; Dezube BJ; Pardee AB
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11044-8. PubMed ID: 8248210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter.
    Biswas DK; Salas TR; Wang F; Ahlers CM; Dezube BJ; Pardee AB
    J Virol; 1995 Dec; 69(12):7437-44. PubMed ID: 7494249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus.
    Li CJ; Wang C; Pardee AB
    J Biol Chem; 1994 Mar; 269(10):7051-4. PubMed ID: 8125909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
    Kelly GD; Morris CB; Offermann MK
    Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.
    Hsu MC; Schutt AD; Holly M; Slice LW; Sherman MI; Richman DD; Potash MJ; Volsky DJ
    Science; 1991 Dec; 254(5039):1799-802. PubMed ID: 1763331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.
    Taylor JP; Pomerantz RJ; Raj GV; Kashanchi F; Brady JN; Amini S; Khalili K
    J Virol; 1994 Jun; 68(6):3971-81. PubMed ID: 8189531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W; Pitha PM
    Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of an HIV-1 Tat antagonist.
    Hsu MC; Schutt AD; Holly M; Slice LW; Sherman MI; Richman DD; Potash MJ; Volsky DJ
    Biochem Soc Trans; 1992 May; 20(2):525-31. PubMed ID: 1397654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells.
    Zhu M; Duan L; Pomerantz RJ
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1093-101. PubMed ID: 8844014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
    Su Y; Popik W; Pitha PM
    J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation.
    Taylor JP; Pomerantz R; Bagasra O; Chowdhury M; Rappaport J; Khalili K; Amini S
    EMBO J; 1992 Sep; 11(9):3395-403. PubMed ID: 1505523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein.
    Ramazzotti E; Vignoli M; Re MC; Furlini G; La Placa M
    AIDS; 1996 May; 10(5):455-61. PubMed ID: 8724035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells.
    Kim YS; Panganiban AT
    J Neurosci Res; 1996 Mar; 43(6):652-66. PubMed ID: 8984195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.